MARKET

ONVO

ONVO

Organovo Holding
NASDAQ
1.110
+0.060
+5.71%
Closed 17:32 03/18 EDT
OPEN
1.080
PREV CLOSE
1.050
HIGH
1.240
LOW
1.050
VOLUME
854.80K
TURNOVER
0
52 WEEK HIGH
2.330
52 WEEK LOW
0.8911
MARKET CAP
11.14M
P/E (TTM)
-0.5112
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ONVO last week (0311-0315)?
Weekly Report · 23h ago
Weekly Report: what happened at ONVO last week (0304-0308)?
Weekly Report · 03/11 10:58
Weekly Report: what happened at ONVO last week (0226-0301)?
Weekly Report · 03/04 11:01
Weekly Report: what happened at ONVO last week (0219-0223)?
Weekly Report · 02/26 11:12
Weekly Report: what happened at ONVO last week (0212-0216)?
Weekly Report · 02/19 11:14
12 Health Care Stocks Moving In Monday's Intraday Session
Renalytix (NASDAQ:RNLX) stock rose 490.4% to $2.25 during Monday's regular session. Regencell Bioscience stock rose 39.91% and Sangamo Therapeutics stock moved upwards by 26.04% in the same session. Other gainers include Genenta Science and T2 Biosystems. AN2 Therapeutic stock decreased by 75.0% during the session.
Benzinga · 02/12 17:31
Weekly Report: what happened at ONVO last week (0205-0209)?
Weekly Report · 02/12 11:05
Organovo: Fiscal Q3 Earnings Snapshot
Barchart · 02/08 16:52
More
About ONVO
Organovo Holdings, Inc. is a biotechnology company that focuses on building high fidelity, three-dimensional (3D) tissues that recapitulate various aspects of human disease. The Company uses these models to identify gene targets responsible for driving the disease and intends to initiate drug discovery programs around these validated targets. It is initially focusing on the intestine and has ongoing 3D tissue development efforts in ulcerative colitis (UC) and Crohns disease (CD). The Company uses its technology to build functional 3D human tissues that mimic various aspects of native human tissue composition, architecture, function, and disease. Its NovoGen Bioprinters are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells. Its NovoGen Bioprinters can also dispense pure hydrogel formulations, provided the physical properties of the hydrogel are compatible with the dispensing parameters. Its 3D human tissue platform is multifaceted.

Webull offers Organovo Holdings Inc stock information, including NASDAQ: ONVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ONVO stock methods without spending real money on the virtual paper trading platform.